Preserving the intellectual output & resources of the University of Missouri.
What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?
MOspace/Manakin Repository
Breadcrumbs Navigation
What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?
Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/4005
| Title: | What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL? |
| Author: | Nelson, Carrie; Hitchcock, Kristin; Bohlen, James A. |
| Keywords: |
coronary artery disease
statin therapy cholesterol |
| Date: | 2009-12 |
| Publisher: | Family Physicians Inquiries Network |
| Citation: | Journal of Family Practice, 58(12) 2009: 665-667. |
| Abstract: | No studies directly compare low-density lipoprotein (LDL) levels <70 mg/dL to levels of 71 to 100 mg/dL in very-high-risk patients. However, no evidence suggests a “floor” for LDL cholesterol levels beyond which further reductions of heart disease risk can't be achieved (strength of recommendation [SOR]: A, systematic reviews of randomized controlled trials [RCTs]). The target LDL cholesterol of <70 mg/dL is based on data extrapolated from RCTs (SOR: B). |
| URI: | http://hdl.handle.net/10355/4005 |
Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.
This item appears in the following Collection(s)
-
Clinical Inquiries, 2009 [51]
The items in this collection constitute volume 58 of Clinical Inquiries.